Path of Workflow Crosswalk
A path of workflow is the description of the necessary processes to deliver the particular product or service that the organization or entity provides. A laboratory path of workflow consists of the sequential processes: preexamination, examination, and postexamination and their respective sequential subprocesses. All laboratories follow these processes to deliver their services, namely quality laboratory information.
To view each element of the path of workflow, click “Filter Off” and select from the dropdown options.
|
Product Code
|
Title
|
Examination ordering
|
Specimen collection
|
Specimen transport
|
Specimen receipt, accessioning, and processing
|
Examination method selection
|
Examination method performance
|
Results review and follow-up
|
Laboratory results interpretation
|
Comm. of alert values & issuance of prel. reports
|
Release of final reports
|
Specimen management
|
N/A
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
AUTO02-A2
|
Laboratory Automation: Bar Codes for Specimen Container Identification
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AUTO03-A2
|
Laboratory Automation: Communications With Automated Clinical Laboratory Systems, Instruments, Devices, and Information Systems
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AUTO04-A
|
Laboratory Automation: Systems Operational Requirements, Characteristics, and Information Elements.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AUTO05-A
|
Laboratory Automation: Electromechanical Interfaces, 1st Edition
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AUTO07-A
|
Laboratory Automation: Data Content for Specimen Identification
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AUTO08-A
|
Managing and Validating Laboratory Information Systems
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AUTO09-A
|
Remote Access to Clinical Laboratory Diagnostic Devices via the Internet
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AUTO10-A
|
Autoverification of Clinical Laboratory Test Results
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AUTO11-A2
|
IT Security of In Vitro Diagnostic Instruments and Software Systems
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AUTO12-A
|
Specimen Labels: Content and Location, Fonts, and Label Orientation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AUTO13-A2
|
Laboratory Instruments and Data Management Systems: Design of Software User Interfaces and End-User Software Systems Validation, Operation, and Monitoring
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AUTO15-Ed1
|
Autoverification of Medical Laboratory Results for Specific Disciplines
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AUTO16-Ed1
|
Next-Generation In Vitro Diagnostic Instrument Interface
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AUTO17-Ed1
|
Semantic Interoperability for In Vitro Diagnostic Systems
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIS01-A2
|
Specification for Low-Level Protocol to Transfer Messages Between Clinical Laboratory Instruments and Computer Systems
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIS02-A2
|
Specification for Transferring Information Between Clinical Laboratory Instruments and Information Systems
|
|
|
|
|
|
|
|
|
|
|
|
|
|
C24-Ed4
|
Statistical Quality Control for Quantitative Measurement Procedures: Principles and Definitions
|
|
|
|
|
|
|
|
|
|
|
|
|
|
C29-A2
|
Standardization of Sodium and Potassium Ion-Selective Electrode Systems to the Flame Photometric Reference Method
|
|
|
|
|
|
|
|
|
|
|
|
|
|
C31-A2
|
Ionized Calcium Determinations: Precollection Variables, Specimen Choice, Collection, and Handling
|
|
|
|
|
|
|
|
|
|
|
|
|
|
C34-Ed4
|
Sweat Testing: Sample Collection and Quantitative Chloride Analysis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
C37-A
|
Preparation and Validation of Commutable Frozen Human Serum Pools as Secondary Reference Materials for Cholesterol Measurement Procedures
|
|
|
|
|
|
|
|
|
|
|
|
|
|
C38-Ed2
|
Control of Preexamination Variation in Trace Element Determinations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
C39-A
|
A Designated Comparison Method for the Measurement of Ionized Calcium in Serum
|
|
|
|
|
|
|
|
|
|
|
|
|
|
C40-Ed3
|
Measurement Procedures for the Determination of Lead Concentrations in Blood and Urine
|
|
|
|
|
|
|
|
|
|
|
|
|
|
C40-A2
|
Measurement Procedures for the Determination of Lead Concentrations in Blood and Urine
|
|
|
|
|
|
|
|
|
|
|
|
|
|
C42-A
|
Erythrocyte Protoporphyrin Testing
|
|
|
|
|
|
|
|
|
|
|
|
|
|
C43-A2
|
Gas Chromatography/Mass Spectrometry Confirmation of Drugs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
C45-A
|
Measurement of Free Thyroid Hormones
|
|
|
|
|
|
|
|
|
|
|
|
|
|
C46-A2
|
Blood Gas and pH Analysis and Related Measurements
|
|
|
|
|
|
|
|
|
|
|
|
|
|
C48-A
|
Application of Biochemical Markers of Bone Turnover in the Assessment and Monitoring of Bone Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|
C49-Ed2
|
Analysis of Body Fluids in Clinical Chemistry
|
|
|
|
|
|
|
|
|
|
|
|
|
|
C50-A
|
Mass Spectrometry in the Clinical Laboratory: General Principles and Guidance
|
|
|
|
|
|
|
|
|
|
|
|
|
|
C52-Ed3
|
Toxicology and Drug Testing in the Clinical Laboratory
|
|
|
|
|
|
|
|
|
|
|
|
|
|
C56-A
|
Hemolysis, Icterus, and Lipemia/Turbidity Indices as Indicators of Interference in Clinical Laboratory Analysis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
C56A-QG
|
Examples of Hemolyzed, Icteric, and Lipemic/Turbid Samples Quick Guide
|
|
|
|
|
|
|
|
|
|
|
|
|
|
C57-Ed1
|
Mass Spectrometry for Androgen and Estrogen Measurements in Serum
|
|
|
|
|
|
|
|
|
|
|
|
|
|
C58-A
|
Assessment of Fetal Lung Maturity by the Lamellar Body Count
|
|
|
|
|
|
|
|
|
|
|
|
|
|
C61-A
|
Determination of Serum Iron, Total Iron-Binding Capacity and Percent Transferrin Saturation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
C62-Ed2
|
Liquid Chromatography-Mass Spectrometry Methods
|
|
|
|
|
|
|
|
|
|
|
|
|
|
C63-Ed1
|
Laboratory Support for Pain Management Programs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
C64-Ed1
|
Quantitative Measurement of Proteins and Peptides by Mass Spectrometry
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP05-A3
|
Evaluation of Precision of Quantitative Measurement Procedures
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP06-Ed2
|
Evaluation of Linearity of Quantitative Measurement Procedures
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP06-Ed2-EG
|
Developer Validation of Linearity Establishment Guide
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP06-Ed2-IG
|
User Verification of Linearity Implementation Guide
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP07-Ed3
|
Interference Testing in Clinical Chemistry
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP09-Ed3c
|
Measurement Procedure Comparison and Bias Estimation Using Patient Samples
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP10-Ed4
|
Preliminary Evaluation of Quantitative Medical Laboratory Measurement Procedures
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP10-A3-AMD
|
Preliminary Evaluation of Quantitative Clinical Laboratory Measurement Procedures
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP10-Ed3-IG
|
Preliminary Evaluation of Quantitative Clinical Laboratory Measurement Procedures Implementation Guide
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP10-Ed4-IG
|
Preliminary Evaluation of Quantitative Medical Laboratory Measurement Procedures Implementation Guide
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP12-Ed3
|
Evaluation of Qualitative, Binary Output Examination Performance
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP12-Ed3-DS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP12-Ed3-IG
|
Evaluation of Qualitative, Binary Output Examination Performance
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP14-Ed4
|
Evaluation of Commutability of Processed Samples
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP15-A3
|
User Verification of Precision and Estimation of Bias
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP15-Ed3-IG1
|
User Verification of Precision Implementation Guide
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP15-Ed3-IG2
|
User Verification of Bias (Trueness) Implementation Guide
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP17-Ed2-IG
|
Evaluation of Detection Capability Implementation Guide
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP17-A2
|
Evaluation of Detection Capability for Clinical Laboratory Measurement Procedures
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP18-A2
|
Risk Management Techniques to Identify and Control Laboratory Error Sources
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP18-Ed2-IG
|
Risk Management Techniques Implementation Guide
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP18-Ed2-EP23-Ed2-WS
|
Laboratory Quality Control Based on Risk Management; Worksheet Template
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP18-A2-EP23-A-WS
|
Laboratory Quality Control Based on Risk Management; Worksheet Template
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP19-Ed3
|
A Framework for Using CLSI Documents to Evaluate Clinical Laboratory Measurement Procedures
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP21-Ed2
|
Evaluation of Total Analytical Error for Quantitative Medical Laboratory Measurement Procedures
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP21-Ed2-IG
|
Total Error Implementation Guide
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP23-Ed2
|
Laboratory Quality Control Based on Risk Management
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP23-A-QG
|
EP23 Quick Reference Guide
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP23-A-WB
|
Laboratory Quality Control Based on Risk Management; Workbook
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP23-A-WS
|
Laboratory Quality Control Based on Risk Management; Worksheet Template
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP23-Ed2-QG
|
EP23 Quick Reference Guide
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP23-Ed2-WB
|
Laboratory Quality Control Based on Risk Management; Workbook
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP24-A2
|
Assessment of the Diagnostic Accuracy of Laboratory Tests Using Receiver Operating Characteristic Curves
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP25-Ed2
|
Evaluation of Stability of In Vitro Medical Laboratory Test Reagents
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP26-Ed2
|
User Evaluation of Acceptability of a Reagent Lot Change
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP26-Ed2-IG
|
User Evaluation of Acceptability of a Reagent Lot Change Implementation Guide
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP27-Ed2
|
How to Construct and Interpret an Error Grid for Quantitative Measurement Procedures
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP28-A3c
|
Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP28-Ed3-IG
|
Verification of Reference Intervals in the Medical Laboratory Implementation Guide
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP29-A
|
Expression of Measurement Uncertainty in Laboratory Medicine
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP30-Ed2
|
Characterization and Qualification of Commutable Reference Materials for Laboratory Medicine
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP30-A
|
Characterization and Qualification of Commutable Reference Materials for Laboratory Medicine
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP31-A-IR
|
Verification of Comparability of Patient Results Within One Health Care System
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP31-Ed1-IG
|
Verification of Comparability of Patient Results Within One Health Care System
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP32-R
|
Metrological Traceability and Its Implementation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP33-Ed2
|
Use of Delta Checks in the Medical Laboratory
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP34-Ed1
|
Establishing and Verifying an Extended Measuring Interval Through Specimen Dilution and Spiking
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP34-Ed1-IG
|
Establishing and Verifying an Extended Measuring Interval Through Specimen Dilution and Spiking
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP35-Ed1
|
Assessment of Equivalence or Suitability of Specimen Types for Medical Laboratory Measurement Procedures
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP36-Ed1
|
Harmonization of Symbology and Equations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP37-Ed1
|
Supplemental Tables for Interference Testing in Clinical Chemistry
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP39-Ed1
|
A Hierarchical Approach to Selecting Surrogate Samples for the Evaluation of In Vitro Medical Laboratory Tests
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP43-Ed1
|
Implementing a Laboratory Test Under Emergency Use Conditions
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EP47-Ed1
|
Evaluation of Reagent Carryover Effects on Test Results
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EPLDT-QG-Ed1
|
Validating Performance Claims for Laboratory-Developed Tests
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MN
|
Method Navigator
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MN v.2
|
Method Navigator
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GP05-A3
|
Clinical Laboratory Waste Management
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GP05-A3-CL
|
Waste Management Program – Audit Checklist
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GP15-A3
|
Cervicovaginal Cytology Based on the Papanicolaou Technique
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GP16-A3
|
Urinalysis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GP17-A3
|
Clinical Laboratory Safety
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GP20-A2
|
Fine Needle Aspiration Biopsy (FNAB) Techniques
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GP23-A2
|
Nongynecologic Cytologic Specimens: Collection and Cytopreparatory Technique
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GP34-A
|
Validation and Verification of Tubes for Venous and Capillary Blood Specimen Collection
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GP36-A
|
Planning for Laboratory Operations During a Disaster
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GP39-A6
|
Tubes and Additives for Venous and Capillary Blood Specimen Collection
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GP40-A4-AMD
|
Preparations and Testing of Reagent Water in the Clinical Laboratory
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GP41-Ed7
|
Collection of Diagnostic Venous Blood Specimens
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GP41-Ed7-QG
|
Quality Venipuncture Quick Guide
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GP42-Ed7
|
Collection of Capillary Blood Specimens
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GP42-A6-QG
|
Technique for Skin Puncture in Adults and Older Children Quick Guide
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GP45-A
|
Studies to Evaluate Patient Outcomes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GP47-Ed1
|
Management of Critical- and Significant-Risk Results.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GP47-ES
|
Critical- and Significant-Risk Laboratory Results: Identification, Reporting, and Management; Executive Summary
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GP48-Ed1
|
Essential Elements of a Phlebotomy Training Program
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GP49-Ed1
|
Developing and Managing a Medical Laboratory (Test) Utilization Management Program
|
|
|
|
|
|
|
|
|
|
|
|
|
|
H02-A5
|
Procedures for the Erythrocyte Sedimentation Rate Test
|
|
|
|
|
|
|
|
|
|
|
|
|
|
H07-A3
|
Procedure for Determining Packed Cell Volume by the Microhematocrit Method
|
|
|
|
|
|
|
|
|
|
|
|
|
|
H15-A3
|
Reference and Selected Procedures for the Quantitative Determination of Hemoglobin in Blood
|
|
|
|
|
|
|
|
|
|
|
|
|
|
H20-A2
|
Reference Leukocyte (WBC) Differential Count (Proportional) and Evaluation of Instrumental Methods
|
|
|
|
|
|
|
|
|
|
|
|
|
|
H21-Ed6
|
Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays
|
|
|
|
|
|
|
|
|
|
|
|
|
|
H21-A5
|
Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays
|
|
|
|
|
|
|
|
|
|
|
|
|
|
H21-A5-QG
|
H21-A5 Quick Guide
|
|
|
|
|
|
|
|
|
|
|
|
|
|
H26-A2
|
Validation, Verification, and Quality Assurance of Automated Hematology Analyzers
|
|
|
|
|
|
|
|
|
|
|
|
|
|
H30-A2
|
Procedure for the Determination of Fibrinogen in Plasma
|
|
|
|
|
|
|
|
|
|
|
|
|
|
H42-A2
|
Enumeration of Immunologically Defined Cell Populations by Flow Cytometry
|
|
|
|
|
|
|
|
|
|
|
|
|
|
H43-A2
|
Clinical Flow Cytometric Analysis of Neoplastic Hematolymphoid Cells
|
|
|
|
|
|
|
|
|
|
|
|
|
|
H44-A2
|
Methods for Reticulocyte Counting (Automated Blood Cell Counters, Flow Cytometry, and Supravital Dyes)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
H47-Ed3
|
One-Stage Prothrombin Time (PT) Test and Activated Partial Thromboplastin Time (APTT) Test
|
|
|
|
|
|
|
|
|
|
|
|
|
|
H48-Ed2
|
Determination of Factor Coagulant Activities Using the One-stage Clotting Assay
|
|
|
|
|
|
|
|
|
|
|
|
|
|
H52-A2
|
Red Blood Cell Diagnostic Testing Using Flow Cytometry
|
|
|
|
|
|
|
|
|
|
|
|
|
|
H54-A
|
Procedures for Validation of INR and Local Calibration of PT/INR Systems
|
|
|
|
|
|
|
|
|
|
|
|
|
|
H56-A
|
Body Fluid Analysis for Cellular Composition
|
|
|
|
|
|
|
|
|
|
|
|
|
|
H57-A
|
Protocol for the Evaluation, Validation, and Implementation of Coagulometers
|
|
|
|
|
|
|
|
|
|
|
|
|
|
H58-A
|
Platelet Function Testing by Aggregometry
|
|
|
|
|
|
|
|
|
|
|
|
|
|
H59-A
|
Quantitative D-dimer for the Exclusion of Venous Thromboembolic Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|
H60-A
|
Laboratory Testing for the Lupus Anticoagulant
|
|
|
|
|
|
|
|
|
|
|
|
|
|
H60-A-QG1
|
Algorithmic Approach to Lupus Anticoagulant Testing
|
|
|
|
|
|
|
|
|
|
|
|
|
|
H60-A-QG2
|
Criteria for the Laboratory Diagnosis of the Lupus Anticoagulant
|
|
|
|
|
|
|
|
|
|
|
|
|
|
H62-Ed1
|
Validation of Assays Performed by Flow Cytometry
|
|
|
|
|
|
|
|
|
|
|
|
|
|
I/LA02-A2
|
Quality Assurance of Laboratory Tests for Autoantibodies to Nuclear Antigens: (1) Indirect Fluorescence Assay for Microscopy and (2) Microtiter Enzyme Immunoassay Methods
|
|
|
|
|
|
|
|
|
|
|
|
|
|
I/LA20-Ed3
|
Analytical Performance Characteristics, Quality Assurance, and Clinical Utility of Immunological Assays for Human Immunoglobulin E (IgE) Antibodies of Defined Allergen Specificities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
I/LA21-A2
|
Clinical Evaluation of Immunoassays
|
|
|
|
|
|
|
|
|
|
|
|
|
|
I/LA23-A
|
Assessing the Quality of Immunoassay Systems: Radioimmunoassays and Enzyme, Fluorescence, and Luminescence Immunoassays
|
|
|
|
|
|
|
|
|
|
|
|
|
|
I/LA25-A2
|
Maternal Serum Screening
|
|
|
|
|
|
|
|
|
|
|
|
|
|
I/LA26-A2
|
Performance of Single Cell Immune Response Assays
|
|
|
|
|
|
|
|
|
|
|
|
|
|
I/LA28-A2
|
Quality Assurance for Design Control and Implementation of Immunohistochemistry Assays
|
|
|
|
|
|
|
|
|
|
|
|
|
|
I/LA28-A2-QG
|
Comparison of the Characteristics of Immunoassays Such as Enzyme-Linked Immunosorbent Assay and Immunohistochemistry Quick Guide
|
|
|
|
|
|
|
|
|
|
|
|
|
|
I/LA30-A
|
Immunoassay Interference by Endogenous Antibodies
|
|
|
|
|
|
|
|
|
|
|
|
|
|
I/LA33-A
|
Validation of Automated Systems for Immunohematological Testing Before Implementation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
I/LA34-A
|
Design and Validation of Immunoassays for Assessment of Human Allergenicity of New Biotherapeutic Drugs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
I/LA37-Ed2 v2
|
Supplemental Data for Allergen Specificity for IgE Antibody Autoanalyzers
|
|
|
|
|
|
|
|
|
|
|
|
|
|
FR01-Ed1
|
Voriconazole Breakpoint for Aspergillus fumigatus
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MR01-Ed2
|
Polymyxin Breakpoints for Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter spp.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MR02-Ed1
|
Fluoroquinolone Breakpoints for Enterobacteriaceae and Pseudomonas aeruginosa
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MR03-Ed1
|
Meropenem Breakpoints for Acinetobacter spp.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MR04-Ed1
|
Azithromycin Breakpoint for Neisseria gonorrhoeae
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MR05-Ed1
|
Ceftaroline Breakpoints for Staphylococcus aureus
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MR06-Ed1
|
Daptomycin Breakpoints for Enterococci
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MR07-Ed1
|
Cefazolin Breakpoints for Enterobacterales for Systemic Infections
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MR08-Ed1
|
Cefazolin Breakpoints for Enterobacterales for Uncomplicated Urinary Tract Infections
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MR14-Ed1
|
Piperacillin-Tazobactam Breakpoints for Enterobacterales
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MR15-Ed1
|
Piperacillin-Tazobactam and P. aeruginosa
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BPI Toolkit
|
BPI Toolkit
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M02-Ed14
|
Performance Standards for Antimicrobial Susceptibility Tests
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M02-Ed14-QG
|
Disk Diffusion Reading Guide
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M02QG
|
Disk Diffusion Reading Guide
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M07-ED12-QG
|
Minimal Inhibitory Concentration Reading Guide
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M07-Ed12
|
Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M11-Ed9
|
Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M15-A
|
Laboratory Diagnosis of Blood-borne Parasitic Diseases
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M22-A3
|
Quality Control for Commercially Prepared Microbiological Culture Media
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M23-Ed6
|
Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M23-Ed5-S-Ed1
|
Procedure for Optimizing Disk Contents (Potencies) for Disk Diffusion Testing of Antimicrobial Agents Using Harmonized CLSI and EUCAST Criteria
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M23-Ed5-S2-Ed1
|
Process to Submit Disk Content (Potency) Data for Joint CLSI-EUCAST Working Group Review and Approval
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M23-ED5-S3-Ed1
|
Procedure for Confirming the Acceptability of Mueller-Hinton Agar Sources for Subsequent Use in CLSI
and/or EUCAST Studies to Establish Disk Diffusion QC Ranges
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M23S3-Ed1-WB
|
Data Collection Workbook for CLSI-EUCAST Mueller-Hinton Agar Acceptability Study
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M24-Ed3
|
Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M24S-Ed2
|
Performance Standards for Susceptibility Testing of Mycobacteria, Nocardia spp., and Other Aerobic Actinomycetes.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M26-A
|
Methods for Determining Bactericidal Activity of Antimicrobial Agents
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M27-Ed4
|
Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M27-M44-S-Ed3
|
Performance Standards for Antifungal Susceptibility Testing of Yeasts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M28-A2
|
Procedures for the Recovery and Identification of Parasites From the Intestinal Tract
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M29-A4
|
Protection of Laboratory Workers From Occupationally Acquired Infections
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M34-A
|
Western Blot Assay for Antibodies to Borrelia burgdorferi
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M35-A2
|
Abbreviated Identification of Bacteria and Yeast
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M36-A
|
Clinical Use and Interpretation of Serologic Tests for Toxoplasma gondii
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M38-Ed3
|
Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M38-M51-S-Ed3
|
Performance Standards for Antifungal Susceptibility Testing of Filamentous Fungi
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M39-Ed5
|
Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M40-A2
|
Quality Control of Microbiological Transport Systems
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M41-A
|
Viral Culture
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M43-A
|
Methods for Antimicrobial Susceptibility Testing for Human Mycoplasmas
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M44-Ed3
|
Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M45-Ed3
|
Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M47-Ed2
|
Principles and Procedures for Blood Cultures
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M48-Ed2
|
Laboratory Detection and Identification of Mycobacteria; Approved Guideline
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M50-A
|
Quality Control for Commercial Microbial Identification Systems
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M51-A
|
Method for Antifungal Disk Diffusion Susceptibility Testing of Nondermatophyte Filamentous Fungi
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M52-Ed1
|
Verification of Commercial Microbial Identification and Antimicrobial Susceptibility Testing Systems
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M53-Ed2
|
Criteria for Laboratory Testing and Diagnosis of Human Immunodeficiency Virus Infection
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M54-Ed2
|
Principles and Procedures for Detection and Culture of Fungi in Clinical Specimens
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M56-A
|
Principles and Procedures for Detection of Anaerobes in Clinical Specimens
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M57-Ed1
|
Principles and Procedures for the Development of Epidemiological Cutoff Values for Antifungal Susceptibility Testing
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M57-S-Ed4
|
Epidemiological Cutoff Values for Antifungal Susceptibility Testing
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M58-Ed1
|
Methods for the Identification of Cultured Microorganisms Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry
|
|
|
|
|
|
|
|
|
|
|
|
|
|
M100-Ed34
|
Performance Standards for Antimicrobial Susceptibility Testing
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MM01-Ed4
|
Molecular Testing for Heritable Genetics and Specimen Identification
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MM03-Ed3
|
Molecular Diagnostic Methods for Infectious Diseases
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MM05-A2
|
Nucleic Acid Amplification Assays for Molecular Hematopathology
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MM06-A2
|
Quantitative Molecular Methods for Infectious Diseases
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MM07-A2
|
Fluorescence In Situ Hybridization Methods for Medical Genetics
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MM09-Ed3
|
Human Genetic and Genomic Testing Using Traditional and High-Throughput Nucleic Acid Sequencing Methods
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MM11-A
|
Molecular Methods for Bacterial Strain Typing
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MM12-A
|
Diagnostic Nucleic Acid Microarrays
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MM13-Ed2
|
Collection, Transport, Preparation, and Storage of Specimens for Molecular Methods
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MM14-A2
|
Design of Molecular Proficiency Testing/External Quality Assessment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MM17-Ed2
|
Verification and Validation of Multiplex Nucleic Acid Assays
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MM18-Ed2
|
Interpretive Criteria for Identification of Bacteria and Fungi by DNA Target Sequencing
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MM19-A
|
Establishing Molecular Testing in Clinical Laboratory Environments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MM20-A
|
Quality Management for Molecular Genetic Testing
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MM21-Ed1
|
Genomic Copy Number Microarrays for Constitutional Genetic and Oncology Applications
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MM22-Ed2
|
Microarrays for Diagnosis and Monitoring of Microbial Infections
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MM22-A
|
Microarrays for Diagnosis and Monitoring of Infectious Diseases
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MM23-Ed1
|
Molecular Diagnostic Methods for Solid Tumors (Nonhematological Neoplasms)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MM24-Ed1
|
Molecular Methods for Genotyping and Strain Typing of Infectious Organisms
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MM26-Ed1
|
Cancer Molecular Testing: Principles of Oncology Test Interpretation, Laboratory and Assay Design, and Clinical Consultation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NBS01-Ed7
|
Blood Collection on Filter Paper for Newborn Screening Programs
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NBS01-Ed7-QG
|
Specimen Collection and Specimen Quality for Newborn Screening Quick Guide
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NBS01OL
|
Making a Difference Through Newborn Screening: Blood Collection on Filter Paper
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NBS02-A2-QG
|
Newborn Screening Follow-up Process Quick Guide
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NBS02-Ed3
|
Newborn Screening Follow-up and Education
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NBS03-Ed2
|
Newborn Screening for Preterm, Low Birth Weight, and Sick Newborns
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NBS04-Ed2
|
Newborn Screening by Tandem Mass Spectrometry
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NBS05-Ed2
|
Newborn Screening for Cystic Fibrosis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NBS06-A
|
NBS for Severe Combined Immunodeficiency by Measurement of T-cell Receptor Excision Circles
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NBS06-A-QG1
|
Generic Flow Chart for Assays to Measure T-cell Receptor Excision Circles in Newborn Dried Blood Spot Specimens Quick Guide
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NBS06-A-QG2
|
Schematic for Preparing Dried Blood Spot Reference Materials Quick Guide
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NBS07-Ed1
|
Newborn Blood Spot Screening for Pompe Disease by Lysosomal Acid α-Glucosidase Activity Assays
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NBS08-Ed1
|
Newborn Screening for Hemoglobinopathies
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NBS09-Ed1
|
Newborn Screening for X-Linked Adrenoleukodystrophy
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NBS10-Ed1
|
Newborn Screening for Congenital Hypothyroidism
|
|
|
|
|
|
|
|
|
|
|
|
|
|
POCT01-A2
|
Point-of-Care Connectivity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
POCT01QG-Ed1
|
CLSI Vendor Code Registry
|
|
|
|
|
|
|
|
|
|
|
|
|
|
POCT02-A
|
Implementation Guide of POCT01 for Healthcare Providers; Approved Guideline
|
|
|
|
|
|
|
|
|
|
|
|
|
|
POCT04-Ed3
|
Essential Tools for Implementation and Management of a Point-of-Care Testing Program
|
|
|
|
|
|
|
|
|
|
|
|
|
|
POCT05-Ed2
|
Performance Metrics for Continuous Interstitial Glucose Monitoring
|
|
|
|
|
|
|
|
|
|
|
|
|
|
POCT06-Ed1
|
Effects of Different Sample Types on Glucose Measurements
|
|
|
|
|
|
|
|
|
|
|
|
|
|
POCT07-A
|
Quality Management: Approaches to Reducing Errors at the Point of Care
|
|
|
|
|
|
|
|
|
|
|
|
|
|
POCT08-A
|
Quality Practices in Noninstrumented Point-of-Care Testing: An Instructional Manual and Resources for Health Care Workers
|
|
|
|
|
|
|
|
|
|
|
|
|
|
POCT08-A-QG1
|
Corrective Action Quick Guide
|
|
|
|
|
|
|
|
|
|
|
|
|
|
POCT08-A-QG2
|
Quality Control Troubleshooting Flow Chart
|
|
|
|
|
|
|
|
|
|
|
|
|
|
POCT08-A-QG3
|
Quality Control Log Sheet Quick Guide
|
|
|
|
|
|
|
|
|
|
|
|
|
|
POCT09-A
|
Selection Criteria for Point-of-Care Testing Devices
|
|
|
|
|
|
|
|
|
|
|
|
|
|
POCT09-A-WS
|
Instrument Selection Worksheet
|
|
|
|
|
|
|
|
|
|
|
|
|
|
POCT10-A2
|
Physician and Nonphysician Provider-Performed Microscopy Testing;
|
|
|
|
|
|
|
|
|
|
|
|
|
|
POCT12-A3
|
Point-of-Care Blood Glucose Testing in Acute and Chronic Care Facilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
POCT13-Ed3c
|
Glucose Monitoring in Settings Without Laboratory Support
|
|
|
|
|
|
|
|
|
|
|
|
|
|
POCT14-Ed2
|
Point-of-Care Coagulation Testing and Anticoagulation Monitoring
|
|
|
|
|
|
|
|
|
|
|
|
|
|
POCT15-Ed1
|
POCT for Infectious Diseases
|
|
|
|
|
|
|
|
|
|
|
|
|
|
POCT17-Ed1
|
Use of Glucose Meters for Critically Ill Patients
|
|
|
|
|
|
|
|
|
|
|
|
|
|
POCT18-Ed1
|
Test Selection Process for CLIA-Waived Complexity Testing for SARS-CoV-2, Respiratory Syncytial Virus, and Influenza
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PRE01-Ed1
|
Patient and Laboratory Specimen Identification Processes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PRE04-Ed1
|
Handling, Transport, Processing, and Storage of Blood Specimens for Routine Laboratory Examinations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PRE05-Ed1
|
Urine Specimen Collection
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QMS01-Ed5
|
A Quality Management System Model for Laboratory Services
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QMS01-CL
|
Gap Analysis Checklists, 1st Edition
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QMS01-Ed5-es
|
Un Modelo de Sistema de Gestión de Calidad Para Servicios de Laboratorio
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QMS02-Ed7
|
Quality Management System: Development and Management of Laboratory Documents
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QMS02-A6
|
Quality Managment System: Development and Management of Laboratory Documents
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QMS02-Ed7-QG
|
Quality Venipuncture Quick Guide
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QMS03-Ed4
|
Training and Competence Assessment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QMS04-Ed3
|
Laboratory Design
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QMS05-Ed3
|
Qualifying, Selecting, and Evaluating a Referral Laboratory
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QMS06-A3
|
Quality Management System: Continual Improvement
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QMS11-Ed2
|
Nonconforming Event Management
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QMS12-Ed2
|
Development and Use of Quality Indicators for Process Improvement and Monitoring of Laboratory Quality
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QMS13-A
|
Quality Management System: Equipment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QMS14-A
|
Quality Management System: Leadership and Management Roles and Responsibilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QMS15-Ed2
|
Assessments: Laboratory Internal Audit Program
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QMS16-Ed1
|
Laboratory Personnel Management
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QMS17-Ed2
|
External Assessments, Audits, and Inspections of the Laboratory
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QMS18-Ed2
|
Process Management
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QMS19-Ed1
|
Customer Focus in a Quality Management System
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QMS20-Ed2
|
The Cost of Quality in Medical Laboratories
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QMS21-Ed1
|
Purchasing and Inventory Management
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QMS22-Ed1
|
Management of Paper-based and Electronic Laboratory Information
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QMS23-Ed2
|
General Laboratory Equipment Performance Qualification, Use, and Maintenance
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QMS24-Ed3
|
Using Proficiency Testing and Alternative Assessment to Improve Medical Laboratory Quality
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QMS25-Ed1
|
Handbook for Developing a Laboratory Quality Manual
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QMS26-Ed1
|
Managing Laboratory Records
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QMS29-Ed1
|
Conducting Effective Management Reviews
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QSRLDT
|
Quality System Regulations for Laboratory-Developed Tests: A Practical Guide for the Laboratory
|
|
|
|
|
|
|
|
|
|
|
|
|
|
VET01-Ed6
|
Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals
|
|
|
|
|
|
|
|
|
|
|
|
|
|
VET01-Ed6-S-Ed7
|
Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals
|
|
|
|
|
|
|
|
|
|
|
|
|
|
VET02-Ed4
|
Development of Quality Control Ranges, Breakpoints, and Interpretive Categories for Antimicrobial Agents Used in Veterinary Medicine
|
|
|
|
|
|
|
|
|
|
|
|
|
|
VET03-Ed2
|
Methods for Antimicrobial Broth Dilution and Disk Diffusion Susceptibility Testing of Bacteria Isolated From Aquatic Animals
|
|
|
|
|
|
|
|
|
|
|
|
|
|
VET04-Ed3
|
Performance Standards for Antimicrobial Susceptibility Testing of Bacteria Isolated From Aquatic Animals
|
|
|
|
|
|
|
|
|
|
|
|
|
|
VET06-Ed1
|
Methods for Antimicrobial Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria Isolated From Animals
|
|
|
|
|
|
|
|
|
|
|
|
|
|
VET09-Ed2
|
Understanding Susceptibility Test Data as a Component of Antimicrobial Stewardship in Veterinary Settings
|
|
|
|
|
|
|
|
|
|
|
|
|